Laboratory Investigation

Papers
(The H4-Index of Laboratory Investigation is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Comprehensive RNA Sequencing Analysis Identifies Network Hub Genes and Biomarkers Differentiating Desmoid-type Fibromatosis From Reactive Fibrosis251
Corrigendum to “386 Targeted NGS for TP53 and BRCA1, BRCA2, Gene Mutations and Comparison with Immune Cell Profiling and Immune Checkpoint Inhibitor Expression in Ascitic Fluid with Metastases from Hi127
Overexpression of COX7A1 Promotes the Resistance of Gastric Cancer to Oxaliplatin and Weakens the Efficacy of Immunotherapy111
Spatiotemporal Cellular Dynamics of Germinal Center Reaction in Coronavirus Disease 2019 Lung-Draining Lymph Node Based on Imaging-Based Spatial Transcriptomics77
FABP4 activates the JAK2/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE mice atherosclerosis68
Alveolar Mitochondrial Quality Control During Acute Respiratory Distress Syndrome57
Gratitude and a Warning54
Role of Stromal Fibroblast–Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma50
Integrated Cytometry With Machine Learning Applied to High-Content Imaging of Human Kidney Tissue for In Situ Cell Classification and Neighborhood Analysis50
INFECTIOUS DISEASE PATHOLOGY49
Editorial Board43
Digital Hepatic Iron Content: An Artificial Intelligence Model for Spatially Resolved Histologic Iron Quantitative Analysis in Liver Samples42
CYTOPATHOLOGY42
Epigenetic Alteration of H3K27me3 as a Possible Oncogenic Mechanism of Central Neurocytoma39
A Transgenic Pig Model With Human Mutant SOD1 Exhibits the Early Pathology of Amyotrophic Lateral Sclerosis39
USCAP 2022 Abstracts: Autopsy and Forensics (1-23)39
783 Papillary Renal Cell Carcinomas with ABCC2 Brush Border Immunoreactivity Reveal Alterations in the NRF2-ARE Signaling and May Be Associated with Resistance to MET-Targeted Therapy38
1002 Endometrial Carcinomas with FGFR2 Activating Variants: Clinicopathologic Features and Potential Therapeutic Targets38
846 Analysis of microRNA 371-373 Cluster and 12p Status in Somatic Carcinomas with Phenotypic Similarities to Yolk Sac Tumor38
Consistency Analysis of Programmed Death Ligand 1 Expression in Non–Small Cell Lung Cancer Between Pleural Effusion and Matched Primary Lung Cancer Tissues by Immunohistochemical Double Staining38
844 Perivascular Epithelioid Cell Tumors of the Urinary Bladder: A Clinicopathologic and Comprehensive Molecular Analysis including Microsatellite Instability Status and Tumor Mutational Burden in a C38
977 The Pitfalls of p16 Immunohistochemistry in Gynecologic Carcinoma36
890 Human Papillomavirus Genotypes and Site of Integration in HPV-Associated Penile Squamous Cell Carcinoma35
849 Aberrant CDX2 Expression in Invasive Urothelial Carcinoma Without Divergent Differentiation: A Clinicopathologic Study of 101 Cases with Next-Generation Sequencing in 20 Cases33
947 Immunohistochemical Expression of PRAME: A Useful Marker to Differentiate Adenocarcinomas of Endocervical vs. Endometrial Origin32
978 CTNNB1 Mutation and L1CAM Expression are Not Mutually Exclusive in Endometrial Cancer32
755 MDM2 Expression in Epithelioid Sarcomas and Other SMARCB1-Deficient Malignancies: Potential Role as a Therapeutic Biomarker?31
879 Expression of Targets of Antibody Drug Conjugates Nectin-4, TROP-2, HER2 and Claudin18 in Bladder Adenocarcinoma and Urothelial Carcinoma with Glandular Differentiation30
914 Poor Clinical Outcomes in Testicular Germ Cell Tumor Teratomas That Fail to Meet Somatic-Type Malignancy Diagnostic Criteria30
751 Aberrant INSM1 Expression in Erythroid Cells: A Potential Diagnostic Pitfall Versus Neuroendocrine Tumors29
0.27282309532166